Chargement en cours...

Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib

About 10-15% of patients with multiple myeloma develop light chain (AL) amyloidosis. AL amyloidosis is a systemic disease that may involve multiple organs, often including the heart. It may present clinically with bradyarrhythmia and syncope. The proteasome inhibitor bortezomib has been used with cl...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hematol Rep
Auteurs principaux: Jaipaul, Navin, Pi, Alexander, Zhang, Zhiwei
Format: Artigo
Langue:Inglês
Publié: PAGEPress Publications, Pavia, Italy 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4961869/
https://ncbi.nlm.nih.gov/pubmed/27499835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2016.6417
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!